Janssen Immunology

Janssen Immunology has revolutionised the way people living with autoimmune diseases are treated, with a portfolio of innovative medicines that optimise the patient journey.

We are committed to helping patients take back their lives and targeting new areas of research to create a future where disease is a thing of the past.

We take the time to listen to what patients need. We understand that it’s not just medicine that helps patients manage their condition.

We are proud to partner with patient groups Crohn’s & Colitis Australia and IBD Support Australia to support the more than 85,000 Australians who live with inflammatory bowel disease every day.

We provide support programs, and information for patients living with Crohn’s Disease and Ulcerative Colitis through the GastroCentral website:  www.gastrocentral.com.au

About the Janssen Pharmaceutical Companies of Johnson & Johnson

At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us.

We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it.

Learn more at www.janssen.com.au  Follow us on Twitter @JanssenANZ

Janssen-Cilag Pty Limited is a part of the Janssen Pharmaceutical Companies of Johnson & Johnson. CP-63035. July 2018


Stand/Booth No. 38